One life was saved for every 456 men invited for a prostate cancer screening, the study found. View on euronews ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific ...

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests.

Prostate specific antigen screening reduces the risk of death from prostate cancer by 13%, one of the largest randomised ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

Prostate cancer screening could prevent around 1,500 deaths a year in the UK, research suggests. A European trial, one of the ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...

Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising concerns about overtesting" warn researchers from the University of Oxford ...

Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found.

After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...